Biofrontera AG
CIK: 0001712641
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BFRI
Biofrontera Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
About Biofrontera AG
Biofrontera AG (SEC CIK 0001712641) files insider reports with the SEC as Director of Biofrontera Inc. (BFRI).
Signal8 holds 2 ownership filings by Biofrontera AG (1 Form 3, 1 Form 4), filed between Jul 9, 2025 and Sep 18, 2025. Those filings report 1 transaction, the latest on Sep 16, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Biofrontera AG's filings is in LEVERKUSEN, 2M.
Recent filings by Biofrontera AG
- Sep 16, 2025: Open-market purchase of BFRI derivative securities (Form 4, code P).
Other insiders filing for Biofrontera Inc. (BFRI)
- Luebbert Hermann, CEO & Chairman
- Leffler Eugene Frederick, Chief Financial Officer
- Weber Kevin Daniel, Director
- Lanckriet Heikki, Director
- Hoffman Beth J., Director
- Jones George Patrick, Chief Commercial Officer